Chief Financial Officer @ (March 2023 - September 2024)
Chief Financial Officer @ (March 2021 - March 2023)
CFO @ (November 2017 - February 2021)
CFO Research and Development Solutions - QuintilesIMS @ (April 2015 - November 2017)
Vice President Investor Relations @ (January 2013 - April 2015)
Vice President Finance - Customer Solutions Management Group @ (February 2012 - January 2013)
Vice President Finance - Asia Australia @ (March 2009 - November 2011)
Executive Director Finance - Global Data Management and Biostatistics @ (January 2007 - March 2009)
Global Head Sarbanes Oxley PMO @ (January 2005 - January 2007)
Internal Audit Director @ (January 2003 - January 2005)
CFO @ (March 2000 - March 2002)
Auditor @ Arthur Andersen (March 1998 - March 2000)
Auditor @ (December 1995 - March 1998)
Karl Deonanan Education
East Carolina University
Master of Science (M.S.) (Accounting)
1994-1995
University of North Carolina Wilmington
Bachelor of Science (B.S.) (Accounting)
1990-1994
Karl Deonanan Skills
Management
Financial Analysis
Pharmaceutical Industry
Finance
Sarbanes-Oxley Act
Strategic Planning
Cross-functional Team Leadership
Leadership
Forecasting
Financial Reporting
Auditing
Accounting
Cross Functional Team
Sales
Financial Modeling
Business Development
Microsoft Office
Cross Functional Team Leadership
Budgets
Sarbanes Oxley Act
Business Strategy
Research
Internal Audit
Development
Product Development
Karl Deonanan Summary
Karl Deonanan, based in Raleigh, NC, US, is currently a Chief Financial Officer at Precision Medicine Group. Karl Deonanan brings experience from previous roles at ProPharma, X-Chem, Inc., Synteract and QuintilesIMS. Karl Deonanan holds a 1994 - 1995 Master of Science (M.S.) in Accounting @ East Carolina University. With a robust skill set that includes Management, Financial Analysis, Pharmaceutical Industry, Finance, Sarbanes-Oxley Act and more. Karl Deonanan has 2 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Karl Deonanan?
Find contact details for 700 million professionals.